Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ASBP

ASBP News

Newswire

09:16

Aspire Biopharma shares surge 11.34% premarket after submitting FDA Pre-IND for sublingual aspirin, citing rapid pharmacology and 505(b)(2) pathway pursuit.

09:03

Aspire Biopharma Seeks FDA Approval for Fast-Acting Sublingual Aspirin for Heart Attack Treatment

04:40

Aspire Biopharma shares surge 10.89% premarket on positive Phase II trial data, $38M funding, and CRO partnership.

04:06

Aspire Biopharma shares surge 20.37% premarket after engaging global pharmaceutical leaders at CPHI Frankfurt to advance partnership discussions for sublingual high-dose aspirin.

09:50

Aspire Biopharma shares rise 18.84% intraday after reporting Q3 results and securing $100M equity credit facility.

View More

About ASBP

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More